Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Effi bi13250670 NEW YORK, Dec. 8, 2011 /PRNewswire/ -- Stemline Therapeutics, Inc. today announced that two studies of SL-401, a clinical stage therapeutic being developed patients myeloid malignancies, have also demonstrated preclinical activity against a variety of lymphoid..

Moffitt investigators to participate 16 oral and 50 posters presentation bi13250670 When the American Society of Hematology convenes 53rd Annual Meeting and Exposition on Dec. 10-13 San Diego, Calif., researchers from Moffitt Cancer Center break a new record for Moffitt participants one plenary presentation, 16 oral presentations and more than 50 presentations on new research results a variety of meeting programs that focus on blood cancer basic ..

Multiple Myeloma Research Consortium to Present Data Eight Oral or Poster bi13250670 NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium (MMRC) today announced that eight abstracts from clinical collaborations academia and industry have been accepted for oral and presentations at year's American Society of Hematology (ASH) Annual Meeting to be held December 10-13, 2011 San Diego, California. In an oral presentation, the MMRC ..

Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Effi bi13250670 NEW YORK, Dec. 8, 2011 /PRNewswire/ -- Stemline Therapeutics, Inc. today announced that two studies of SL-401, a clinical stage therapeutic being developed patients myeloid malignancies, have also demonstrated preclinical activity against a variety of lymphoid..

Moffitt investigators to participate 16 oral and 50 posters presentation bi13250670 When the American Society of Hematology convenes 53rd Annual Meeting and Exposition on Dec. 10-13 San Diego, Calif., researchers from Moffitt Cancer Center break a new record for Moffitt participants one plenary presentation, 16 oral presentations and more than 50 presentations on new research results a variety of meeting programs that focus on blood cancer basic ..

Multiple Myeloma Research Consortium to Present Data Eight Oral or Poster bi13250670 NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium (MMRC) today announced that eight abstracts from clinical collaborations academia and industry have been accepted for oral and presentations at year's American Society of Hematology (ASH) Annual Meeting to be held December 10-13, 2011 San Diego, California. In an oral presentation, the MMRC ..

UH Seidman Cancer Center researchers present at American Society of Hematolog bi13250670 ( University Hospitals Case Medical Center ) Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings 25 presentations weekend at the 53rd Annual Meeting of the American Society of Hematology at the San Diego Convention Center

Filipino Doctor Wins Best Presentation for Study on Dexmedetomidine Sepsis bi13250670 16 December 2011 - The Philippine Consulate General Hong Kong reported to the Department of Foreign Affairs that Filipino doctor Michael M. Manio bested the other doctorate students who presented presentations of studies by being awarded best presentation for study In vivo administration of LPS reduces dexmedetomidine-induced contraction isolated rat aortae at the ..

UH Seidman Cancer Center Researchers Present Findings at American Society of bi13250670 CLEVELAND, Dec. 10, 2011 /PRNewswire/ -- Researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine presented new research findings 25 presentations weekend at the 53rd Annual Meeting of..

Florida Cancer Researchers Will Be Strong Participants In American Society Of bi13250670 When the American Society of Hematology convenes 53rd Annual Meeting and Exposition on Dec. 10-13 San Diego, Calif., researchers from Moffitt Cancer Center break a new record for Moffitt participants one plenary presentation, 16 oral presentations and more than 50 presentations on new research results a variety of meeting programs that focus on blood cancer basic ..

Avila Therapeutics to Present at the 2011 American Society of Hematology Annu bi13250670 BEDFORD, Mass.--(BUSINESS WIRE)--Two presentations on AVL-292,(Btk) inhibitor, be presented at the 2011 American Society of Hematology (ASH) Annual meeting..

Moffitt researchers be strong participants American Society of Hemato bi13250670 ( H. Lee Moffitt Cancer Center & Research Institute ) When the American Society of Hematology convenes 53rd Annual Meeting and Exposition on Dec. 10-13 San Diego, Calif., researchers from Moffitt Cancer Center break a new record for Moffitt participants one plenary presentation, 16 oral presentations and more than 50 presentations on new research results a variety of ..

Pinoy doctor cited for best medical presentation Hong Kong bi13250670 Filipino doctor Michael Manio was cited for giving the best medical study presentation at the Hong Kong University early month, the Philippine Consulate General Hong Kong reported

Adult Babies Wearing Diapers - Home